OPEN Health brings together deep scientific knowledge, global understanding, and broad specialist expertise to support our clients in improving health outcomes and patient wellbeing.
We are united as one flexible organization, harnessing the power of the collective to solve complex challenges. Our global team of experts — many with PhD or PharmD degrees — work strategically alongside our client partners in Medical Affairs, Health Economics and Outcomes Research (HEOR), Market Access, and Commercial teams across a wide range of therapy areas.
OPEN Health: Established as many. United as one.
We enhance market access and medical communications to improve patient outcomes
Being built from cohesive partnerships across a range of specialist sectors gives us the ability to approach opportunities from fresh perspectives each and every day, creating solutions and innovations informed by the experience and knowledge of the many.
By looking through multiple lenses, we utilize digital and analytical techniques to create innovative, customized, patient-centric solutions.
We partner with clients across each and every phase of a product's lifecycle
Our broad range of specialist expertise, across many Centers of Excellence, allows our clients the flexibility to work with one expert team or to harness the power of the collective to solve complex challenges through all phases of the product lifecycle.
We are committed to using our talents, skills and resources in ways that can do the most good for our people, our communities, and the environment around us.Everyone at OPEN Health is able to submit an idea for a CSR initiative or activity, so all staff can garner support for causes close to their hearts and participate in the busy calendar of events – whether it’s raising money, raising awareness, or supporting a great cause.
CRISIS * Action Against Hunger * Cardiac Risk in the Young * NHS Blood Donation * Breast Cancer Research UK * Breast Cancer Research Foundation * Sickle Cell Society * Marie Curie * Bowel Cancer UK * M4RD * Young Enterprise Scheme * Alexander Devine * PID UK * Duchenne's UK * IFOPA * Vasculitis UK * Great Ormond Street Hospital * Community Emergency Foodbank * York Foodbank * Refugee Accompanying Program of the Berlin City Mission * Foodbank Rotterdam * Leadership Montgomery * The Loveland Foundation * Pajama Program * St. Jude Children's Research Hospital * Feeding America *
Each year we collate and publish all the great work have been involved in through our CSR activities.
![]() Louise CarringtonGlobal Client Partnerships Director, OPEN Health CommunicationsLouiseCarrington@OpenHealthGroup.comView LinkedIn profile |
![]() Trish ShepherdGlobal Head of Business Development, OPEN Health Communicationstrishshepherd@openhealthgroup.com |
OPEN Health, a preeminent global provider of consulting, HEOR and market access, patient engagement, and scientific and creative communications services, is bringing together experts in strategic patient innovation and engagement, deepening the organization's existing commitment to building patient-first solutions.
OPEN Health Presenting Innovative Research on Capitalizing Data for Patient Access at ISPOR Europe
Dom Marchant, Chief Creative Officer, joins the executive leadership team at OPEN Health with a new vision to drive the creative communications practice
OPEN Health is pleased to announce the appointment of Richard Jones as President for Evidence & Access.
Following its acquisition by OPEN Health in 2022, The CM Group, a US healthcare agency offering a suite of solutions to the biotech and pharma industry, has undergone extensive rebranding and will now be known as OPEN Health.
OPEN Health to acquire leading US-based life science strategy and advisory firm Acsel Health
OPEN Health has announced additions to its board of directors, appointing David P. King as non-executive Chairman and Paul Carter as an independent board member.
OPEN Health is pleased to announce the appointment of Stephen J. Chick as Chief Growth Officer for OPEN Health Evidence & Access.
OPEN Health, a pre-eminent global provider of scientific communications and market access services, announced that it signed a binding agreement to acquire The CM Group, a leading US domestic medical communications platform from NaviMed Capital (“NaviMed”).
The pandemic has forced pharmaceutical industry to look at digital in a new way - and it’s driving better health outcomes
David Thompson joins OPEN Health as Chief Executive Officer for Evidence & Access
OPEN Health Appoints Chief Medical Officer Annemarie Clegg, MD, and Chief Commercial Officer Jennifer Chilver
OPEN Health is pleased to announce the appointment of Margot Hannah as the new Chief Executive Officer of OPEN Health Communications
OPEN Health has today announced the acquisition of London-based agency ARK to further strengthen omnichannel capabilities
OPEN Health has today announced the acquisition of North West UK-based medical communications agency Spirit.
We are delighted to announce our selection in the top 50 of 100 North American healthcare agencies as ranked by Medical, Marketing & Media (MM&M).
OPEN Health is moving to one brand to create a world-class integrated services model
We are delighted to announce that OPEN Health Medical Communications was named Medical Affairs Agency of the Year at the virtual 2020 Communiqué Awards ceremony on 02 July 2020.
Turning scientific knowledge and data into evidence
OPEN Health has today announced the integration of Pharmerit International, a global leader in health economics and outcomes research (HEOR), into its group of companies.
OPEN Health Group have appointed Rob Pilbrow into the newly formed role of Global Managing Director, Medical Writing.
OPEN Health Medical Communications has announced the promotion of two members of its senior leadership team. Jen van Zwieten and Margot Hannah become Group Managing Directors, with responsibility to oversee and drive the strategic goals for the medical communications teams in Europe.
The right measurement frameworks matter for demonstrating treatment efficacy in clinical trials for Alzheimer’s Disease
This whitepaper will explore multidisciplinary perspectives on how we can better engage patient communities in publications to optimize the value of their contributions, while navigating any uncertainties and reluctance from internal and external stakeholders.
If you're interested in delving deeper into this topic and understanding how patient engagement can effectively navigate the nocebo effect, we invite you to explore our latest whitepaper.
Learn how to unlock the power of simplicity in complex omnichannel healthcare communications.
Innovative methods in oncology modeling are needed to demonstrate the value of many new cancer treatments, including immuno-oncologic therapies.
You know your team needs training. But not all training providers and programs are created equal. Last week, we shared the benefits of working with specialist learning and development (L&D) teams to maximize your training investment. Once you’ve identified some potential collaborators, it’s time to take a closer look at what should be in the packages your training provider offers. Here are six vital features you should prioritize to select the training that will help your team fulfil their potential as partners in delivering high-quality and effective healthcare to patients.
Medical affairs teams must train regularly to stay up to date with existing and emerging therapy areas, products, and devices. But finding time to train is tough, so what can you do to ensure your training programs are as cost-effective, time-efficient, and high quality as possible?
We asked Laura Glover to give us an insight into her role as a PR Account Director at OPEN Health
To mark Rare Disease Day 2021 on Sunday 28 February, OPEN Health will be intentionally quiet on all LinkedIn channels from 26 February to 1 March in order not to distract from awareness generated by patient groups.
Join OPEN VIE and Pharmerit – an OPEN Health Company at the ISPOR European Virtual Conference from 16-19 November 2020 to see how we are shaping the healthcare industry with innovative research methods and world-class communications.
Gavin Jones, Director of Rare Disease, provides his thoughts on last week’s NORD Breakthrough Summit and a collective need to reduce inequalities in rare disease
Hear from OPEN Health's Briony Frost
We asked Becca McConnell to give us an insight into her role as Senior Account Executive at OPEN Health.
OPEN Health’s Beth Lesher and Annemarie Clegg examine what the convergence of medical communications and market access means for pharmaceutical companies.
Hear from Trish Shepherd COO, Patient & Brand Communications, OPEN Health
OPEN Health introduce an overview of regulatory and HTA developments for digital therapeutics in Europe focusing on Germany and the UK
We asked Mina Patel to give us an insight into her role as Global Head of Publications at OPEN Health
Explore more with OPEN Health
Our Director of Rare Disease, Gavin Jones looks forward to his conversation with Emily Crossle & Betsy Bogard at #WODCUSA2020 !
Ditch the Label – it’s just me.
Summary of their recently published white paper on gene therapy followed by a Q&A session on 12th June 2020. Book now!
Ben Speller shares his thoughts on the value of disease specific congresses
International Clinical Trials Day finds clinical research in the spotlight like never before, with any news coming from the many studies into potential vaccines and treatments for SARS-CoV-2
Gavin Jones, Director or Rare Disease, attends the congress to better understand the viewpoints of patient groups, health systems and payers
Gavin Jones is looking forward to sessions on innovation in advanced therapies and working towards equitable access.
Charity fundraising for Motor Neuron Disease
Richard Jones introduces our Head of Health Psychology (Dr Sumira Riaz)
Margot Hannah, Partner and Group Managing Director, and CSR lead at OPEN Health shares her thoughts on our latest report.
Gavin Jones shares his thoughts on why congress is so important at this time and the key sessions he is looking forward to.
Annie Rankin how we can work smarter with healthcare professionals
Shortlisted for Best Patient-Centric Approach for 2020 BOBI Awards.
Stacey Osafo, Senior Account Manager, talks about some practical steps she uses for successful virtual meetings and events based on OPEN Health’s vast experience
Written by Briony Frost , OPEN Health
Paul Morrissey, Global Business Director, OPEN Health
Written by OPEN Health's Chris Hodgson, Neil Rees, Sumira Riaz and Karen Petticrew
Louise Carrington and Gemma Allen, OPEN Health
OPEN VIE (Amanda Pulfer, Strategic Director and Sergio Diaz, Patient Centred Outcomes Consultant) were delighted to speak at the Medical Affairs Leaders Forum yesterday.
Celeste Kolanko, Managing Director, Liberum OPEN Health
Emily Wigginton, Client Services Director, OPEN Health Patient & Brand Communications
OPEN Health’s Richard Jones, Gemma Allen and Charlotte Richards discuss how pharma can utilise tools, channels and stakeholders to deliver change and enable better outcomes.
OPEN Health champions CSR over Christmas by giving back to the community and increasing our activities and efforts
Celeste Kolanko, Managing Director of Liberum, OPEN Health takes 15 minutes to answer some key questions on independent medical education.
OPEN Health joined a number of rare disease patients, patient groups and industry representatives at the Regent Street cinema in London to see the winners announced at the Rare Film Festival – an awards ceremony that celebrates and showcases films that raise awareness of rare disease.
Written by Briony Frost, OPEN Health
Written by Gavin Jones, OPEN Health
Enhanced expertise to deliver impactful internal training programmes for healthcare clients
Gavin Jones, Director of Rare Disease, OPEN Health takes 15 minutes to answer some key questions on healthcare communications in gene therapy
New for 2020, OPEN Health is pleased to announce its sponsorship of MedComms Networking
Isobel Owens shares her experience of the OPEN Health Graduate Programme from OPEN VIE to OPEN Health Medical Communications
Gemma Allen, Head of Digital Communications, OPEN Health takes 15 minutes to answer some key questions on digital in medical communications
Gene therapy and advanced cell-based therapies offer patients hope and the potential to make them ‘chronically well’.
A recent blog, published by Sarah Tressel Gary and Rinah Yamamoto called “Patient-Reported Outcome Data in Oncology Trials - Part 2: Clinical Benefit and Patient Preference”, has sparked our interest. This blog has been written to provide commentary on a topical issue relating to the use of Patient-Reported Outcomes (PROs) in oncology trials.
Neil Rees, Head of Research, OPEN Health Patient & Brand Communication takes 15 minutes to answer some key questions on insights and market research in pharma
Having just returned from a very busy but hugely enjoyable few days at congress, I wanted to share our views on the event and key themes that our healthcare communications practices took away from the discussions and presentations.
By Chris Hodgson, Neil Rees, Sumira Riaz and Karen Petticrew While we can all agree that the value of developing a patient journey map cannot be underestimated when exploring the care pathway for a patient, there appear to be inconsistencies within the same pharmaceutical organisations as to how patient journey mapping is defined.
Harnessing the power of collaborations to bring real insights and improve outcomes
Vicky Bramham, Managing Director, OPEN Health takes 15 minutes to answer some key questions on PR discipline.
Rob Pilbrow, Global Managing Director, Medical Writing, OPEN Health takes 15 minutes to answer some key questions on scientific writing
Marie Little, Managing Director, OPEN Health Patient & Brand Communications takes 15 minutes to answer some key questions on healthcare advertising
As part of the OPEN Health CSR programme one of the charities we support is Alexander Devine. They are a local Children's Hospice based in Maidenhead who provide a truly heart-warming service to children and their families at very tough times in their lives.
Sumira Riaz, Health Psychologist at OPEN Health Patient & Brand Communications, takes 15 minutes to answer some key questions on patient-centricity in pharma.
Richard Jones, Managing Director Patient Engagement, OPEN Health Patient and Brand Communications, takes 15 minutes to answer some key questions on patient engagement in pharma
Carwyn Jones, Senior Partner at OPEN Health, takes 15 minutes to answer some key questions on the procurement function in pharma.
The third plenary session at ISPOR in New Orleans focused on affordability in the face of new and expensive therapies and asked the question “is affordability driving a need to revolutionise drug pricing?”
During our graduate induction period in September 2018, we were asked to find a charity that could benefit from the expertise of the OPEN Health practices. We made the decision to work with the XP Support Group (XPSG), which is a charity based in High Wycombe that works with individuals affected by Xeroderma pigmentosum (XP).
Address:
The Weighbridge
Brewery Courtyard
High Street
Marlow
Buckinghamshire
SL7 2FF
United Kingdom